, and have been calibrated for such settings. Their applicability to low transmission settings is unclear. Evaluations of the efficiency of different deployment strategies in diverse settings should consider uncertainties in model structure. dynamics, with differing assumptions about immune decay, transmission heterogeneity, and treatment access, was constructed. After fitting to an extensive library of field data, each model was used to predict the likely health benefits of RTS,S deployment, via EPI (with or without catch-up vaccinations), supplementary vaccination of school-age children, or mass vaccination every 5 y. Settings with seasonally varying transmission, with overall pre-intervention entomological inoculation rates (EIRs) of two...
BACKGROUND: The RTS,S/AS01 vaccine for Plasmodium falciparum malaria demonstrated moderate efficacy ...
Prophylactic vaccination is a powerful tool for reducing the burden of infectious diseases, due to a...
The impact of influenza vaccination is largely measured by estimating vaccine effectiveness (VE), wh...
<div><h3>Background</h3><p>The RTS,S malaria vaccine may soon be licensed. Models of impact of such ...
A number of different malaria vaccine candidates are currently in pre-clinical or clinical developme...
The RTS,S/AS01 pre-erythrocytic malaria vaccine is in phase III clinical trials. It is critical to a...
Background A wide range of possible malaria vaccines is being considered and there is a need to i...
Background A wide range of possible malaria vaccines is being considered and there is a need to i...
We predict the effects of introduction of a pre-erythrocytic vaccine against Plasmodium falciparum i...
OBJECTIVE: To evaluate the cost-effectiveness of introducing the RTS,S malaria vaccine into the Expa...
<p>Mass vaccination of the population was simulated under different model assumptions of mosquito mo...
Abstract OBJECTIVE: To evaluate the cost-effectiveness of introducing the RTS,S malaria vaccine ...
grantor: University of TorontoUsing epidemic simulations in randomly mixing and stratifie...
AbstractObjectiveTo evaluate the cost-effectiveness of introducing the RTS,S malaria vaccine into th...
AbstractA licensed malaria vaccine would provide a valuable new tool for malaria control and elimina...
BACKGROUND: The RTS,S/AS01 vaccine for Plasmodium falciparum malaria demonstrated moderate efficacy ...
Prophylactic vaccination is a powerful tool for reducing the burden of infectious diseases, due to a...
The impact of influenza vaccination is largely measured by estimating vaccine effectiveness (VE), wh...
<div><h3>Background</h3><p>The RTS,S malaria vaccine may soon be licensed. Models of impact of such ...
A number of different malaria vaccine candidates are currently in pre-clinical or clinical developme...
The RTS,S/AS01 pre-erythrocytic malaria vaccine is in phase III clinical trials. It is critical to a...
Background A wide range of possible malaria vaccines is being considered and there is a need to i...
Background A wide range of possible malaria vaccines is being considered and there is a need to i...
We predict the effects of introduction of a pre-erythrocytic vaccine against Plasmodium falciparum i...
OBJECTIVE: To evaluate the cost-effectiveness of introducing the RTS,S malaria vaccine into the Expa...
<p>Mass vaccination of the population was simulated under different model assumptions of mosquito mo...
Abstract OBJECTIVE: To evaluate the cost-effectiveness of introducing the RTS,S malaria vaccine ...
grantor: University of TorontoUsing epidemic simulations in randomly mixing and stratifie...
AbstractObjectiveTo evaluate the cost-effectiveness of introducing the RTS,S malaria vaccine into th...
AbstractA licensed malaria vaccine would provide a valuable new tool for malaria control and elimina...
BACKGROUND: The RTS,S/AS01 vaccine for Plasmodium falciparum malaria demonstrated moderate efficacy ...
Prophylactic vaccination is a powerful tool for reducing the burden of infectious diseases, due to a...
The impact of influenza vaccination is largely measured by estimating vaccine effectiveness (VE), wh...